News
This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...
Last year over 100 people fell ill, with at least 14 having to be treated in hospital after being infected by two rare ...
The NHS has issued an alert to UK households over a 'highly contagious' illness, with two main symptoms which often persist ...
23h
Zacks Small Cap Research on MSNNNVC: NanoViricides Set to Initiate Phase 2 Trial in MPoxNNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results